Search Results - "Ryysy, L"

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study by Yki-Järvinen, H, Kauppinen-Mäkelin, R, Tiikkainen, M, Vähätalo, M, Virtamo, H, Nikkilä, K, Tulokas, T, Hulme, S, Hardy, K, McNulty, S, Hänninen, J, Levänen, H, Lahdenperä, S, Lehtonen, R, Ryysy, L

“…Aims/hypothesis In type 2 diabetic patients we compared 9 months of combination therapy with insulin glargine and metformin with 9 months of NPH insulin…”
Get full text

Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients by Ryysy, L, Häkkinen, A M, Goto, T, Vehkavaara, S, Westerbacka, J, Halavaara, J, Yki-Järvinen, H

“…Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements…”
Get full text

Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus : A randomized, controlled trial by YKI-JÄRVINEN, H, RYYSY, L, NIKKILÄ, K, TULOKAS, T, VANAMO, R, HEIKKILÄ, M

“…Compared with other insulin regimens, combination therapy with oral hypoglycemic agents and bedtime insulin produces similar improvement in glycemic control…”
Get full text

Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes by Kuusi, T, Yki-Järvinen, H, Kauppinen-Mäkelin, R, Jauhiainen, M, Ehnholm, C, Kauppila, M, Seppälä, P, Viikari, J, Kujansuu, E, Rajala, S

“…In order to evaluate whether Lp(a), a lipoprotein that is potentially thrombogenic and atherogenic, is a potential risk factor for CAD in non-insulin-dependent…”
Get more information

Improvement of Glycemic Control by 1 Year of Insulin Therapy Leads to a Sustained Decrease in sE-Selectin Concentrations in Type 2 Diabetes by Ryysy, Leena, Yki-Järvinen, Hannele

“…Improvement of Glycemic Control by 1 Year of Insulin Therapy Leads to a Sustained Decrease in sE-Selectin Concentrations in Type 2 Diabetes Leena Ryysy , MD…”
Get full text

Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus by YKI-JÄRVINEN, H, RYYSY, L, TULOKAS, T, VIIKARI, J, TASKINEN, M.-R, KAUPPILA, M, KUJANSUU, E, LAHTI, J, MARJANEN, T, NISKANEN, L, RAJALA, S, SALO, S, SEPPÄLÄ, P

“…An initial improvement in glycemic control is often followed by gradual deterioration of glycemia during insulin treatment of patients with…”
Get full text

Comparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes Mellitus by Yki-Järvinen, Hannele, Kauppila, Marjut, Kujansuu, Eila, Lahti, Jorma, Marjanen, Tapani, Niskanen, Leo, Rajala, Sulo, Ryysy, Leena, Salo, Seppo, Seppälä, Pentti, Tulokas, Timo, Viikari, Jorma, Karjalainen, Jukka, Taskinen, Marja-Riitta

“…SOME patients with non-insulin-dependent diabetes mellitus (NIDDM) achieve good glycemic control when they are first treated with an oral hypoglycemic drug,…”
Get full text

Antihypertensive action of drug combination: Timolol, hydralazine, hydrochlorothiazide and triamterene by Pörsti, P, Jalonen, K, Ryysy, L, Toivonen, T, Viherkoski, M

“…A fixed combination tablet containing 5 mg of timolol, 25 mg of hydralazine, 25 mg of hydrochlorothiazide and 37.5 mg of triamterene was prepared and its…”
Get more information

Increased frequency of islet cell antibodies in unaffected brothers of children with type 1 diabetes by Eskola, Vesa, Vähäsalo, Paula, Akerblom, Hans K, Knip, Mikael

“…To assess the relation between islet cell antibody (ICA) positivity and demographic characteristics in an extensive series of first-degree relatives of…”
Get more information